Walter R, Mamolo C, Welch V, Brockbank J, Cawson M, Knight C, Wilson M. Budget-impact analysis for gemtuzumab ozogamicin in CD33+ acute Myeloid Leukemia. Poster presented at the XXXVII World Congress International Society of Hematology (ISH); September 14, 2018. Vancouver, Canada.